Left Atrial Volume and Mortality in Patients With Aortic Stenosis

Dan Ruşinaru1,2, Yohann Bohbot2, Cédric Kowalski2, Anne Ringlé3, Sylvestre Maréchaux3,1, Christophe Tribouilloy1,2
1INSERM U‐1088, Jules Verne University of Picardie, Amiens, France
2Pôle Coeur‐Thorax‐Vaisseaux, Department of Cardiology, University Hospital Amiens, Amiens, France
3Groupement des Hôpitaux de l'Institut Catholique de Lille/Faculté libre de médecine, Université Lille Nord de France, Lille, France

Tóm tắt

Background Left atrium ( LA ) enlargement is common in patients with aortic stenosis ( AS ), yet its prognostic implications are unclear. This study investigates the value of left atrial volume ( LAV ) and LAV normalized to body size for predicting mortality in AS . Methods and Results We included 1351 patients with AS in sinus rhythm at diagnosis and analyzed the occurrence of all‐cause death during follow‐up with medical and surgical management. Five parameters of LA enlargement were tested: nonindexed LAV and normalized LAV by ratiometric ( LAV /body surface area [ BSA ] and LAV /height) and allometric ( LAV / BSA 1.7 and LAV /height 2.0 ) scaling. For each parameter, patients in the highest quartile were at high risk of death, whereas outcome was better and similar for the other quartiles. Five‐year survival was lower for patients with LAV >95 mL and LAV / BSA >50 mL/m 2 compared with those with no or mild LA enlargement (both P <0.001). After adjustment for established outcome predictors, including surgery, high risk of death was observed with LAV >95 mL (adjusted hazard ratio, 1.40 [95% confidence interval, 1.06–1.88]) and LAV / BSA >50 mL/m 2 (adjusted hazard ratio, 1.42 [95% confidence interval, 1.08–1.91]). LAV / BSA and LAV showed good and similar predictive performance, whereas other scaling methods did not show better outcome prediction. In patients with severe AS at baseline, preserved (≥50%) ejection fraction, and no or minimal symptoms, LA enlargement was significantly associated with mortality (adjusted hazard ratio, 1.87 [95% confidence interval, 1.02–3.44] for LAV >95 mL, and adjusted hazard ratio, 1.90 [95% confidence interval, 1.03–3.56] for LAV / BSA >50 mL/m 2 ). Conclusions LA enlargement is an important predictor of mortality in AS , incrementally to known predictors of outcome. LAV and LAV / BSA have comparable predictive performance and should be assessed in clinical practice for risk stratification.

Từ khóa


Tài liệu tham khảo

10.1016/j.jacc.2014.02.537

10.1093/eurheartj/ehs109

10.1016/j.jacc.2006.03.002

10.1016/j.jtcvs.2007.12.042

10.1016/j.jtcvs.2012.12.016

10.1016/0735-1097(93)90595-R

10.1161/CIRCIMAGING.112.973834

10.1016/j.acvd.2016.05.010

10.1016/j.amjcard.2007.11.048

10.1016/j.echo.2016.01.011

10.1161/CIRCIMAGING.113.000636

10.1161/CIRCIMAGING.116.005156

10.1016/S0002-9149(01)01460-6

10.1161/01.CIR.92.4.835

10.1001/archinte.165.15.1788

10.1016/j.amjcard.2005.05.031

10.1161/01.CIR.89.2.724

10.1016/S0735-1097(02)02305-7

10.1161/01.CIR.0000066318.21784.43

10.1016/j.jacc.2010.02.059

10.1111/j.1540-8175.2009.01002.x

10.1016/j.jacc.2005.08.077

10.1016/0002-8703(91)90200-2

10.1016/j.ahj.2003.03.001

10.1111/echo.12184

10.1016/0021-9681(87)90171-8

10.1016/j.jacc.2014.09.080

10.1016/S0002-9149(99)00446-4

10.1016/j.amjcard.2015.08.018

10.1097/HJH.0000000000000922

10.1002/sim.4085

10.1002/sim.5647

10.1016/j.jacc.2006.02.048

10.1016/j.echo.2005.10.005

10.1016/j.echo.2014.10.003

10.1016/S0002-9149(00)01019-5

10.1161/CIRCULATIONAHA.107.736785